Part 2; Society of Biological Psychiatry, Pfizer Pharmaceuticals, AstraZeneca, Takeda Pharmaceuticals. Part 4; Johnson and Johnson (grant to VA but not personally to my laboratory), AstraZeneca. Effects of the Glycine Transporter Typ1 Inhibitor RG1678 in Schizophrenic Patients with Predominant ...
function, and connectivity. Extensive neuroimaging literature exists on the comparison of either disorders with matched healthy controls, and a variety of methods have been used to assess brain structure, metabolism, and the spatial and
“This is not something that you consider first line for patients because this is invasive,” said Maguire, chair of psychiatry and neuroscience at the University of California Riverside medical school, and part of the team evaluating whether Larsen was a good candidate for deep brain stimulation...